norwest-venture-partners
(4)
Dave Zilberman
Dave Zilberman is a General Partner at Norwest Venture Partners, where he focuses on early-to-late-stage investments in enterprise software, SaaS, cybersecurity, cloud infrastructure, data, and media. With over 20 years building companies as operator, advisor, and investor, he spent 15 years at Comcast Ventures before joining Norwest in 2020. His portfolio includes landmark wins like Slack (acquired by Salesforce) and DocuSign (Nasdaq: DOCU), and his current bets span AI infrastructure plays like LlamaIndex and security companies like Orion Security.
Dror Nahumi
Dror Nahumi is a General Partner at Norwest Venture Partners, a multi-stage global VC firm managing $15.5 billion in assets. Based in Menlo Park, California, he leads Norwest's Israeli investment portfolio - a practice he helped build since the firm established its Israel presence in 2009. A former Bell Labs research engineer who developed the RCELP speech coder (now the CDMA standard for North American cellular), Nahumi transitioned from deep tech to entrepreneurship before landing in venture capital in 2010. He has backed companies that have been acquired by Microsoft, Google, EMC, and Symantec, and has seeded unicorns including Gong.io, VAST Data, and Weka.
Robert Mittendorff
Dr. Robert Mittendorff is General Partner and Global Head of Healthcare at B Capital, one of the world's leading multi-stage global investment firms with over $6 billion in assets under management. An MD, MBA, and biomedical engineer rolled into one, he brings the rare combination of clinical credibility, operating experience, and investment acumen to healthcare venture capital. He led B Capital's inaugural $500M+ Healthcare Fund I, backing category-defining companies across digital health, medtech, biotech, and AI-driven healthcare from seed to IPO.
Zack Scott
Zack Scott is a General Partner and Co-Head of the Healthcare Investment Team at Norwest Venture Partners, one of Silicon Valley's most active multi-stage venture capital firms. A rare combination of clinically trained physician and seasoned investor, Scott brings an MD from UT Health San Antonio and an MBA from Duke's Fuqua School of Business to a career that spans surgical residency, healthcare venture investing at Burrill & Company, co-founding Revelation Partners (a healthcare-focused secondary investment firm), and now leading healthcare deals at Norwest. His portfolio includes companies like ShiraTronics, SetPoint Medical, Cytovale, and Galvanize Therapeutics, with notable exits including Omada Health's IPO and acquisitions by Stryker, Zoll Medical, Abbott, and Olympus.